Androgen antagonists in androgen target tissues.
D000014:Abnormalities, Drug-Induced; D000152:Acne Vulgaris / Q000188:drug therapy; D000726:Androgen Antagonists / Q000032:analysis / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D001667:Binding, Competitive; D055598:Chemical Phenomena; D002621:Chemistry; D003272:Contraceptive Agents, Male; D005260:Female; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy; D011629:Puberty, Precocious / Q000188:drug therapy; D011944:Receptors, Androgen / Q000032:analysis / Q000378:metabolism*; D011987:Receptors, Steroid / Q000378:metabolism*; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy; D013256:Steroids / Q000032:analysis / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity
D000726:Androgen Antagonists; D003272:Contraceptive Agents, Male; D011944:Receptors, Androgen; D011987:Receptors, Steroid; D013256:Steroids